Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Polycystic ovarian syndrome (PCOS), is a prevalent endocrine disorder that is distinguished by hyperandrogenaemia, chronic anovulation, and polycystic ovary morphology, and metabolic abnormalities. Serum SHBG levels may also be helpful as a treatment target and diagnostic biomarker for treating PCOS in women, according to new research. Anovulation, the phenotypic features of PCOS, and the advancement of ovarian pathology are all caused by decreased SHBG levels, which also increase the...
Published on: Tue, 16 Sep 2025 06:00:00 -0400
Authors: S Abinaya, L Nivethitha, N Manavalan, A Mooventhan,
CONCLUSION: Acupuncture is an effective non-pharmacological intervention for PCOS-related ovulatory dysfunction, with its efficacy dependent on precise dosing parameters. These findings highlight the need for standardized protocols in future trials to validate dose-response thresholds and to optimize personalized treatment strategies.
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Jiale Wei, Zheng Shen, ChunYan Zhao, ChunLin Xie, HongFa Bai, JiaHui Yin, Jian Wang,
CONCLUSION: Among patients with PCOS, those with low BMI had the lowest live birth rate following fresh embryo transfer. The optimal BMI associated with the highest live birth rate was approximately 22 kg/m².
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Nianjun Su, Lijing Wang, Ruiqiong Zhou, Yang Liao, Juan Huang, Cuiyu Huang, Yangcheng Yao, Quan Qi, Li Huang, Xiqian Zhang, Fenghua Liu,
CONCLUSION: FGF19 may be involved in PCOS occurrence and development through the regulation of the FGFR4-ERK-NRF2 pathway.
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Junjie Qu, Meiting Qiu, Jingyun Wang, Zhiqin Chen, Miaoxin Chen, Xiaoming Teng, Yiran Li,
CONCLUSION: Our PCOS-MetS interaction-based EC risk prediction model showed robust and consistent performance across multiple validation cohorts. This tool significantly improves early detection accuracy and holds substantial clinical promise, laying the foundation for personalized EC risk management strategies.
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Qian Xu, Xue Wu, Yabin Guo,
CONCLUSION: Although this study is a small one and was done in a single center, it supports the importance of PCOS in adolescent girls associated with or predisposing to other diseases such as HTN. Careful evaluation and close observation of these patients is critical because early diagnosis and management can prevent late and serious complications.
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Asim Abbas, Aida Vahidi, Mastaneh Moghtaderi,
Polycystic ovary syndrome is distinguished by alterations in ovarian morphology, ovulatory failure, and increased androgen levels. The National Institutes of Health (NIH) defines it as ovulatory dysfunction accompanied by hyperandrogenism. Women with PCOS may have obesity, type 2 diabetes, anxiety, hypertension, insulin resistance, and pregnancy-related complications. PCOS is additionally linked with a greater chance of cardiovascular and metabolic disorders. Several factors, including LH/FSH...
Published on: Mon, 15 Sep 2025 06:00:00 -0400
Authors: Saloni Upadhyay, Avijit Mazumder, Saumya Das,
CONCLUSIONS: Non-neoplastic gynecological diseases pose major public health challenges in low-resource settings, necessitating targeted interventions for rising infertility and PCOS. Population growth served as the primary driver of the increased burden of gynecological diseases.
Published on: Sun, 14 Sep 2025 06:00:00 -0400
Authors: Dongqing Gu, Mengling Qi, Rui Gui, Dan Zhou, Chengying Su, Pan Hu, Lubin Liu,
CONCLUSIONS: In the current analysis, PCOS was independently associated with increased T2DM incidence across all BMI categories. Moreover, the elevated BMI in PCOS patients confers additional T2DM risk mediated by excess adiposity. This BMI-mediated risk exceeds the risk associated with PCOS through other mechanisms, such as hyperandrogenism.
Published on: Sun, 14 Sep 2025 06:00:00 -0400
Authors: Konstantin Sharafutdinov, Jan Hilpert, Rolf Burghaus, Christian Diedrich, Jörg Lippert, Christian Scheerans, Steffen Schaper,
CONCLUSIONS: Current evidence does not support the routine use of rsERT for personalized embryo transfer in PCOS patients without RIF. Further large-scale, well-designed clinical trials are needed.
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Jingjing Chen, Jianjuan Zhao, Qin Hu, Jing Fu, Jing Zhao, Qiong Zhang, Bin Xu, Hui Li, Yanping Li,
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic condition beginning during the peripubertal years. The international evidence-based guidelines and the update in 2023 have clearly defined the diagnostic criteria during adolescence with the goal of decreasing controversies and challenges with the diagnosis during this critical life stage. In this narrative review we aimed to examine the recent available data related to the diagnosis of PCOS during adolescence. Specifically, we...
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Alexia Sophie Peña, Selma Feldman Witchel,
This study investigates the effect of the quercetin/cyclodextrin (Que/β-CD) complex on oxidative stress, cytochrome P450 gene expression, and ovarian tissue structure in a rat polycystic ovary syndrome (PCOS) model. The Que/β-CD complexes were synthesized using the solvent evaporation method and characterized via scanning electron microscope (SEM) imaging and fourier transform infrared (FTIR) spectroscopy. Thirty female Wistar rats (6 weeks old, 160-180 g) with regular estrous cycles were...
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Fatemeh Taghipour, Hadi Samadian, Razieh Dalirfardouei, Sara Soleimani Asl, Nastaran Barati, Tayebe Artimani,
Polycystic ovary syndrome (PCOS) is a systemic endocrine metabolic disorder that seriously affects women's reproductive health. This study aimed to investigate the mechanism by which NAD^(+) precursors inhibits granulosa cell (GCs) pyroptosis induced by increased phosphatidylinositol (PI) levels in PCOS. Metabolomic profiling of PCOS patients demonstrated significant lipid metabolic disturbances, with differentially metabolites significantly enriched in phosphatidylinositol signaling, pyroptosis...
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Xiuli Yang, Kongwei Huang, Jinfang Qin, Xueying Cui, Zhihan Zhang, Qiumei Huang, Yafei Wu, Xiaocan Lei, Shun Zhang,
Polycystic ovarian syndrome (PCOS) is an endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and metabolic disturbances. A balanced gut microbiome plays an important role in managing homeostatic signalling pathways in the body. These pathways regulate normal bodily functions but can become dysregulated under dysbiotic conditions. Recent research has highlighted the role of gut microbiota in the pathogenesis of polycystic ovarian syndrome. Key Bacterial taxa such as...
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Vaishnavi A Pathak, Sanjay J Kshirsagar, Gitanjali S Deokar,
Introdution: Hypertension (HTN), metabolic syndrome (MetS), and obesity are common in women with polycystic ovary syndrome (PCOS); these comorbidities may be more common in non-Hispanic Black (NHB) and Hispanic women with PCOS. Methods: We examined electronic health records in an academic health care system using International Classification of Diseases, Tenth Revision, diagnostic codes to identify PCOS cases (n = 4,479) and control women (n = 771). We examined associations between PCOS and...
Published on: Sat, 13 Sep 2025 06:00:00 -0400
Authors: Faith Okifo, Lubna Pal, Margaret Mushi, Nina Stachenfeld,